About Index Trending news
Analyze
Top 50 Pricing
AntriaBio

AntriaBio

Work at AntriaBio? Add yourself to this profile

AntriaBio

AntriaBio is developing proprietary products in sustained release injectable formulations including AB101, a once-a-week basal insulin. $ANTB

Elsewhere

Alexa global traffic share

Twitter followers

21 Mar 2016
$4,350,000
Venture capital (Series A)

SEC FORM D

sec
+1
16 Apr 2015
$2,000,000
Venture capital
14 Apr 2014
$7,296,453
Venture capital
14 Jan 2014
$1,420,000
Debt financing
14 Jan 2013
$825,000
Debt financing
16 Aug 2012
$1,825,000
Debt financing